Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Methylphenidate and venlafaxine attenuate locomotion in spontaneously hypertensive rats, an animal model of attention-deficit/hyperactivity disorder, through α2-adrenoceptor activation.

Umehara M, Ago Y, Kawanai T, Fujita K, Hiramatsu N, Takuma K, Matsuda T.

Behav Pharmacol. 2013 Aug;24(4):328-31. doi: 10.1097/FBP.0b013e3283633648.

PMID:
23751518
2.

[Behavioral and pharmacological studies of juvenile stroke-prone spontaneously hypertensive rats as an animal model of attention-deficit/hyperactivity disorder].

Ueno K, Togashi H, Yoshioka M.

Nihon Shinkei Seishin Yakurigaku Zasshi. 2003 Feb;23(1):47-55. Review. Japanese.

PMID:
12690641
3.

Drug reinforcement in a rat model of attention deficit/hyperactivity disorder--the Spontaneously Hypertensive Rat (SHR).

Vendruscolo LF, Izídio GS, Takahashi RN.

Curr Drug Abuse Rev. 2009 May;2(2):177-83. Review.

PMID:
19630747
4.

Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.

Wilens TE.

J Clin Psychopharmacol. 2008 Jun;28(3 Suppl 2):S46-53. doi: 10.1097/JCP.0b013e318173312f. Review.

PMID:
18480677
5.

Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?

Dela Peña I, Kim BN, Han DH, Kim Y, Cheong JH.

Arch Pharm Res. 2013 Apr;36(4):400-10. doi: 10.1007/s12272-013-0037-2. Epub 2013 Mar 8. Review. Erratum in: Arch Pharm Res. 2013 May;36(5):650. Kim, Bung-Nyun [added]; Han, Doug Hyun [added]; Kim, Yeni [added].

PMID:
23471559
6.

Use of serotonin norepinephrine reuptake inhibitors in the treatment of attention-deficit hyperactivity disorder in pediatrics.

Park P, Caballero J, Omidian H.

Ann Pharmacother. 2014 Jan;48(1):86-92. doi: 10.1177/1060028013506561. Epub 2013 Oct 9. Review.

PMID:
24259607
7.

[Comorbidity between attention deficit/hyperactivity disorder and substance use disorders: evidence from animal models].

Vendruscolo LF, Takahashi RN.

Rev Bras Psiquiatr. 2011 Jun;33(2):203-8. Review. Portuguese.

8.

Spontaneously hypertensive rat (SHR) as an animal model for ADHD: a short overview.

Meneses A, Perez-Garcia G, Ponce-Lopez T, Tellez R, Gallegos-Cari A, Castillo C.

Rev Neurosci. 2011;22(3):365-71. doi: 10.1515/RNS.2011.024. Epub 2011 May 13. Review.

PMID:
21591908
9.

Psychopharmacology of ADHD: children and adolescents.

Findling RL, Dogin JW.

J Clin Psychiatry. 1998;59 Suppl 7:42-9. Review.

10.

Stimulants: Therapeutic actions in ADHD.

Arnsten AF.

Neuropsychopharmacology. 2006 Nov;31(11):2376-83. Epub 2006 Jul 19. Review.

11.
13.

Does serotonin deficit mediate susceptibility to ADHD?

Banerjee E, Nandagopal K.

Neurochem Int. 2015 Mar;82:52-68. doi: 10.1016/j.neuint.2015.02.001. Epub 2015 Feb 12. Review.

PMID:
25684070
14.

Dysfunctions in dopamine systems and ADHD: evidence from animals and modeling.

Viggiano D, Vallone D, Sadile A.

Neural Plast. 2004;11(1-2):97-114. Review.

15.

α2 Adrenoceptor: a Target for Neuropathic Pain Treatment.

Di Cesare Mannelli L, Micheli L, Crocetti L, Giovannoni MP, Vergelli C, Ghelardini C.

Mini Rev Med Chem. 2017;17(2):95-107. Review.

PMID:
27292786

Supplemental Content

Support Center